Shares of GlobeImmune Inc (OTCMKTS:GBIM) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.09 and traded as high as $0.12. GlobeImmune shares last traded at $0.12, with a volume of 100 shares.

The business’s fifty day simple moving average is $0.09 and its two-hundred day simple moving average is $0.12.

GlobeImmune Company Profile (OTCMKTS:GBIM)

GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.

Further Reading: Sell-Side Analysts

Receive News & Ratings for GlobeImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeImmune and related companies with's FREE daily email newsletter.